August 29, 2014

Immucor to Host Debt Investor Conference Call on Thursday, September 4, 2014

NORCROSS, Ga., August 29, 2014 – Immucor, Inc., a global leader in transfusion and transplantation diagnostics, today announced that it will hold a conference call with debt investors on Thursday, September 4, 11 a.m. ET to discuss its fiscal 2014 fourth quarter results.

Interested debt investors and analysts should contact Immucor Investor Relations at investor-requests@immucor.com or 770-441-2051 for details.

About Immucor
Founded in 1982, Immucor is a global leader in transfusion and transplantation diagnostics that facilitate patient-donor compatibility. Our mission is to ensure that patients in need of blood, organs or stem cells get the right match that is safe, accessible and affordable. With the right match, we can transform a life together. For more information on Immucor, please visit our website at www.immucor.com.

FOR IMMEDIATE RELEASE
CONTACT: Michele Howard
770-441-2051


Close window | Back to top

Copyright 2017 Immucor, Inc.